Literature DB >> 10561090

Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.

T Kosuge1, J Yamamoto, K Shimada, S Yamasaki, M Makuuchi.   

Abstract

OBJECTIVE: To evaluate the long-term outcome of aggressive surgery incorporating hepatic resection and systematic nodal dissection for advanced carcinoma involving the hepatic hilus. SUMMARY BACKGROUND DATA: Few long-term results are available regarding radical surgery incorporating major hepatectomy and nodal dissection.
METHODS: A retrospective analysis was undertaken in 107 patients with carcinoma involving the hepatic hilus treated between 1980 and 1997. Resectional surgery was performed in 65 patients, 52 of whom underwent major hepatectomies. The effects of clinical and pathologic factors were assessed by univariate and multivariate analyses.
RESULTS: Sixty percent of the patients with resectional surgery had stage IVA or IVB disease, and 92.3% of them underwent major hepatectomies. No in-hospital deaths were encountered in the 35 most recent resections, whereas there were six deaths in the early period. Resectional surgery was associated with a survival benefit, especially when resection margins were free from cancerous infiltration. The estimated 5-year survival rate after resection, including all deaths, was 34.8%; this was 51.6% when the margins were clear. Nodal involvement was documented in 44.6% of the resections. However, patients with metastases limited to the regional nodes showed a survival rate similar to that in patients without nodal involvement. Significant predictive factors for survival after resection were extension to the gallbladder, nodal status, resectional margins, histologic type, and gender.
CONCLUSIONS: The combination of major hepatectomy with systematic nodal dissection gave a good chance of prolonged survival for patients with carcinoma involving the hepatic hilus, even when the disease was advanced. Less-extensive procedures were also beneficial for less-advanced disease if clear resectional margins were secured.

Entities:  

Mesh:

Year:  1999        PMID: 10561090      PMCID: PMC1420920          DOI: 10.1097/00000658-199911000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

1.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

2.  Carcinoma of the exocrine pancreas: a sex hormone responsive tumour?

Authors:  B A Greenway
Journal:  Br J Surg       Date:  1987-06       Impact factor: 6.939

3.  Surgical treatment of hilar carcinoma of the bile duct.

Authors:  R Mizumoto; Y Kawarada; H Suzuki
Journal:  Surg Gynecol Obstet       Date:  1986-02

4.  Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts.

Authors:  L H Blumgart; N S Hadjis; I S Benjamin; R Beazley
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

5.  Prolongation of survival for carcinoma at the hepatic duct confluence.

Authors:  S Tashiro; T Tsuji; K Kanemitsu; Y Kamimoto; T Hiraoka; Y Miyauchi
Journal:  Surgery       Date:  1993-03       Impact factor: 3.982

6.  Aggressive surgical therapy for Klatskin tumors.

Authors:  T Childs; M Hart
Journal:  Am J Surg       Date:  1993-05       Impact factor: 2.565

Review 7.  Long-term survivors after salvage surgery combined with radiotherapy for recurrence of stage IV main hepatic duct cancer--report of two cases.

Authors:  T Todoroki; Y Fukuda; T Kawamoto; Y Saida; K Ohara; Y Iwasaki; O Matsuzaki
Journal:  Hepatogastroenterology       Date:  1993-06

8.  Outcomes after curative resections of cholangiocarcinoma.

Authors:  D M Nagorney; J H Donohue; M B Farnell; C D Schleck; D M Ilstrup
Journal:  Arch Surg       Date:  1993-08

9.  Improvements in survival by aggressive resections of hilar cholangiocarcinoma.

Authors:  H U Baer; S C Stain; A R Dennison; B Eggers; L H Blumgart
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

10.  Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas.

Authors:  Y Ogura; R Mizumoto; M Tabata; S Matsuda; T Kusuda
Journal:  World J Surg       Date:  1993 Jan-Feb       Impact factor: 3.352

View more
  95 in total

Review 1.  Photodynamic therapy in the biliary tract.

Authors:  M Ortner
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

3.  Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?

Authors:  Anthony T Ruys; Fiebo J W Ten Kate; Olivier R Busch; Marc R Engelbrecht; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-09-26       Impact factor: 3.647

Review 4.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

5.  One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.

Authors:  Tsuyoshi Sano; Kazuaki Shimada; Yoshihiro Sakamoto; Junji Yamamoto; Susumu Yamasaki; Tomoo Kosuge
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

6.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

7.  Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer.

Authors:  Tatsuharu Yamada; Toshiyuki Arai; Masato Nagino; Koji Oda; Junichi Shoda; Hiroshi Suzuki; Yuichi Sugiyama; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-06-17       Impact factor: 3.445

8.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.

Authors:  Yasuji Seyama; Keiichi Kubota; Keiji Sano; Tamaki Noie; Tadatoshi Takayama; Tomoo Kosuge; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

10.  Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?

Authors:  Kevin Tri Nguyen; Jennifer Steel; Tsafrir Vanounou; Allan Tsung; J Wallis Marsh; David A Geller; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2009-09-23       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.